JP2020525407A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020525407A5 JP2020525407A5 JP2019566125A JP2019566125A JP2020525407A5 JP 2020525407 A5 JP2020525407 A5 JP 2020525407A5 JP 2019566125 A JP2019566125 A JP 2019566125A JP 2019566125 A JP2019566125 A JP 2019566125A JP 2020525407 A5 JP2020525407 A5 JP 2020525407A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- per day
- subject
- composition
- crofelemer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762513251P | 2017-05-31 | 2017-05-31 | |
| US62/513,251 | 2017-05-31 | ||
| PCT/US2018/035468 WO2018222919A1 (en) | 2017-05-31 | 2018-05-31 | Methods and compositions for treating congenital diarrhea disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020525407A JP2020525407A (ja) | 2020-08-27 |
| JP2020525407A5 true JP2020525407A5 (https=) | 2021-07-26 |
Family
ID=64455032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019566125A Pending JP2020525407A (ja) | 2017-05-31 | 2018-05-31 | 先天性下痢障害を治療するための方法及び組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11857510B2 (https=) |
| EP (1) | EP3634581B8 (https=) |
| JP (1) | JP2020525407A (https=) |
| CN (1) | CN110831667A (https=) |
| AU (1) | AU2018278312B2 (https=) |
| CA (1) | CA3065797A1 (https=) |
| DK (1) | DK3634581T3 (https=) |
| ES (1) | ES2988850T3 (https=) |
| FI (1) | FI3634581T3 (https=) |
| IL (1) | IL270984B1 (https=) |
| JO (1) | JOP20190275B1 (https=) |
| WO (1) | WO2018222919A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7328153B2 (ja) | 2017-05-31 | 2023-08-16 | ナポ ファーマシューティカルズ インク． | 胆汁酸性下痢、小腸切除又は胆嚢除去及び短腸症候群に関連する下痢を治療するための方法及び組成物 |
| US11857510B2 (en) | 2017-05-31 | 2024-01-02 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating congenital diarrhea disorder |
| CA3182864A1 (en) * | 2020-06-19 | 2021-12-23 | Lisa A. CONTE | Methods and compositions for treating chemotherapy-induced diarrhea |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3564370D1 (en) | 1985-08-30 | 1988-09-22 | Nestle Sa | Dietetic product with depurating and antidiarrheal activity and process for its preparation |
| US5211944A (en) | 1990-10-12 | 1993-05-18 | Shaman Pharmaceuticals, Inc. | Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
| SI9011933A (sl) | 1990-10-15 | 1998-06-30 | TANIN SEVNICA Kemična industrija p.o. | Kostanjev taninski ekstrakt, postopek za njegovo pridobivanje in njegova uporaba |
| EP2060183A3 (en) | 1996-10-16 | 2009-06-03 | Napo Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| US7767203B2 (en) | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| WO2000047062A2 (en) | 1999-02-01 | 2000-08-17 | Shaman Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same |
| US7235573B2 (en) | 2002-09-30 | 2007-06-26 | The Regents Of The University Of California | Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors |
| US20070254050A1 (en) | 2006-05-01 | 2007-11-01 | Quart Barry D | Method for treatment of diarrhea-predominant irritable bowel syndrome |
| SI2241318T1 (sl) | 2006-05-01 | 2013-04-30 | Napo Pharmaceuticals, Inc. | Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo |
| ES2616012T3 (es) | 2006-05-01 | 2017-06-09 | Napo Pharmaceuticals, Inc. | Composiciones para tratar o prevenir enfermedad inflamatoria del intestino |
| AU2010303577B2 (en) | 2009-10-06 | 2015-10-22 | Napo Pharmaceuticals, Inc. | Methods of treating diseases with proanthocyanidin oligomers such as crofelemer |
| CN107595836A (zh) | 2010-10-31 | 2018-01-19 | 纳珀制药公司 | 用于治疗hiv相关性腹泻的方法和组合物 |
| EP3393460A4 (en) * | 2015-12-23 | 2019-09-25 | Vanessa Research, Inc. | COMPOSITIONS AND METHODS FOR TREATING MVID AND RELATED DISEASES |
| US11389424B2 (en) | 2017-03-09 | 2022-07-19 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating chemotherapy-induced diarrhea |
| JP7328153B2 (ja) | 2017-05-31 | 2023-08-16 | ナポ ファーマシューティカルズ インク． | 胆汁酸性下痢、小腸切除又は胆嚢除去及び短腸症候群に関連する下痢を治療するための方法及び組成物 |
| US11857510B2 (en) | 2017-05-31 | 2024-01-02 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating congenital diarrhea disorder |
-
2018
- 2018-05-31 US US16/617,463 patent/US11857510B2/en active Active
- 2018-05-31 JP JP2019566125A patent/JP2020525407A/ja active Pending
- 2018-05-31 AU AU2018278312A patent/AU2018278312B2/en active Active
- 2018-05-31 EP EP18810153.9A patent/EP3634581B8/en active Active
- 2018-05-31 JO JOJO/P/2019/0275A patent/JOP20190275B1/ar active
- 2018-05-31 DK DK18810153.9T patent/DK3634581T3/da active
- 2018-05-31 ES ES18810153T patent/ES2988850T3/es active Active
- 2018-05-31 CA CA3065797A patent/CA3065797A1/en active Pending
- 2018-05-31 CN CN201880043974.4A patent/CN110831667A/zh active Pending
- 2018-05-31 FI FIEP18810153.9T patent/FI3634581T3/fi active
- 2018-05-31 WO PCT/US2018/035468 patent/WO2018222919A1/en not_active Ceased
-
2019
- 2019-11-27 IL IL270984A patent/IL270984B1/en unknown
-
2023
- 2023-11-27 US US18/520,464 patent/US20240325346A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020510016A5 (https=) | ||
| Kim | Short-chain fatty acids in ulcerative colitis | |
| Alipoor et al. | White adipose tissue browning in critical illness: a review of the evidence, mechanisms and future perspectives | |
| JP6446134B2 (ja) | 癌幹細胞治療用組成物 | |
| JP2020525407A5 (https=) | ||
| TR201815668T4 (tr) | Obezite tedavisine yönelik bileşikler ve bunların kullanım metotları. | |
| JP2020523375A5 (https=) | ||
| Klein | Preventive and therapeutic efficacy of halofuginone-lactate against Cryptosporidium parvum in spontaneously infected calves: a centralised, randomised, double-blind, placebo-controlled study | |
| KR20220080120A (ko) | 위장 건강 조성물 | |
| Scheen et al. | 10 Therapy for obesity—today and tomorrow | |
| Alam et al. | Efficacy of partially hydrolyzed guar gum-added oral rehydration solution in the treatment of severe cholera in adults | |
| JP6360172B2 (ja) | チグリンアルデヒドを使用する組成物及び方法 | |
| JP3604710B2 (ja) | 骨粗鬆症予防及び治療剤 | |
| CN108619283B (zh) | 一种用于改善脂质代谢、减少内脏脂肪的组合物 | |
| CN104001177A (zh) | 一种治疗ii型糖尿病或代谢综合征的复方药物组合物 | |
| CN115884764A (zh) | 用于治疗乙型冠状病毒感染的半胱胺前体化合物 | |
| Duvoisin et al. | Bromocriptine as an adjuvant to levodopa | |
| Kume et al. | THU0199 Tofacitinib improves left ventricular mass and cardiac output in patients with rheumatoid arthritis | |
| JP2016525133A (ja) | クミンアルデヒドを使用する組成物及び方法 | |
| CN104415320A (zh) | 治疗和预防痛风配方 | |
| JP2025147719A (ja) | 腎機能障害改善剤 | |
| Fior et al. | A Case of Non-Hodgkin's Lymphoma. | |
| Shelotkar et al. | A case study on Ritukala Shodhana (seasonal purification therapy) in childhood bronchial asthma | |
| JP2019218317A (ja) | 低体温の予防又は改善剤 | |
| JP2016183172A (ja) | 高脂肪食への嗜好性を軽減させるための医薬組成物、飲食品組成物または飲食品添加剤 |